Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Nicorette Extra Mint vs Nicorette Mint Gum in Healthy Smokers
NCT03259607Phase 1Completed
- Sponsor
- McNeil Laboratories
- Start
- Aug 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of nicotine in tobacco dependence (4 arms), sponsored by McNeil Laboratories. Primary endpoints: Peak Plasma Concentration, Area under the plasma concentration versus time curve from time zero to the last measurable concentration and 1 more. Started Aug 2017; status: completed.
02
Drugs
nicotine
03
Conditions
tobacco dependence
Beyond the preview
Go deeper on NCT03259607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03259607.